CD Diagnostics
- Company typePrivate
- Founded2008
- HeadquartersClaymont, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
CD Diagnostics firmographics
Firmographics- Name
- CD Diagnostics
- Legal name
- CD Diagnostics
- Website
- https://cddiagnostics.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
CD Diagnostics industry classification
Industry- Product category
- Orthopedic In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Companion Diagnostics (CDx) & Precision Medicine IVD (HLAHAAAJ)
- akta.pro secondary industries
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Companion Diagnostics (CDx) & Therapy Selection Assays (HLAAALAF)
Keywords
Where CD Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Claymont
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CD Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Diagnostic Test Kits and Consumables: CD Diagnostics generates revenue through the sale of proprietary diagnostic test kits including the Synovasure Alpha Defensin Lateral Flow Test Kit, ELISA Test, Control Kits, and Microbial Identification Tests. These are sold to hospitals, orthopedic surgery centers, and clinical laboratories for use in periprosthetic joint infection diagnosis.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
CD Diagnostics product offering
Product offeringCore offering
CD Diagnostics develops and sells proprietary immunoassay-based diagnostic test kits under the Synovasure brand for detecting periprosthetic joint infection (PJI) in synovial fluid via alpha defensin biomarkers. The portfolio includes a point-of-care lateral flow test kit, a laboratory-based ELISA test, microbial identification tests, a quality control kit, and the SynTuition laboratory developed test. These products are sold to orthopedic surgeons, hospitals, and clinical laboratories globally.
Product overview
CD Diagnostics, now part of Zimmer Biomet, offers the Synovasure® brand of diagnostic products for joint pain diagnosis, specifically targeting periprosthetic joint infection (PJI) detection. The product portfolio centers on the Synovasure® Alpha Defensin Lateral Flow Test Kit as the core point-of-care offering, complemented by laboratory-based Synovasure® Alpha Defensin ELISA testing for quantitative analysis. Supporting products include quality control (Control Kit), microbial identification tests for broad microorganism detection and P.acnes-specific identification, and the SynTuition™ laboratory-developed test. These products work together to provide comprehensive diagnostic support for joint infection assessment, from rapid lateral flow screening to detailed laboratory analysis.
Differentiator
Problem solved
Functional benefit
Brands
- Synovasure: Diagnostic product line including Alpha Defensin Lateral Flow Test, Alpha Defensin Control Kit, Alpha Defensin ELISA Test, Microbial Identification Test, and SynTuition for joint pain diagnosis and periprosthetic joint infection (PJI) testing.
Products and services
- Synovasure Alpha Defensin Lateral Flow Test Kit
- Synovasure Alpha Defensin ELISA Test A laboratory-based ELISA immunoassay for the quantitative measurement of alpha defensin in synovial fluid, providing reproducible results to support periprosthetic joint infection diagnosis. Used by clinical and reference laboratories.
- Synovasure Microbial Identification Test A test kit for identifying microorganisms in synovial fluid samples to support diagnosis of joint infections, used alongside alpha defensin testing.
- Synovasure Microbial Identification Test – P.acnes A specialized test kit for the identification of Cutibacterium acnes (P.acnes) in joint fluid samples, supporting detection of a specific pathogen relevant to periprosthetic joint infection.
- SynTuition A Laboratory Developed Test (LDT) offering that supports diagnostic workflows for periprosthetic joint infection in laboratory settings.
Companies that use CD Diagnostics
Customer profileSegments2 records
Ideal customer profiles2 records
CD Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CD Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Zimmer BiometcoreCD Diagnostics was acquired by Zimmer Biomet and now operates under the Zimmer Biomet brand. The Synovasure diagnostic product line is integrated into Zimmer Biomet's broader musculoskeletal and diagnostics portfolio. CD Diagnostics' website redirects to Zimmer Biomet, and products are branded as 'Zimmer Biomet Synovasure Diagnostics'. The company maintains its own contact information and technical support operations.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
CD Diagnostics competitors and assessment
Company assessmentDirect peers
- Accelerate Diagnostics: Develops rapid phenotypic antimicrobial susceptibility and identification diagnostics for serious infections, with a clinical focus on bloodstream and orthopedic-related infections. Directly comparable in mission (rapid pathogen diagnostics for critical infections) and customer overlap with hospital infection workups that include PJI.
Emerging players
- T2 Biosystems: Molecular diagnostics company focused on rapid detection of sepsis-causing pathogens directly from whole blood. Offers an alternative diagnostic modality (molecular vs. immunoassay) for infection workups and competes in adjacent hospital-infection decision-making pathways.
- Inflammatix: Host-response diagnostics company developing rapid tests to distinguish bacterial vs. viral infection and stratify sepsis. Comparable as an emerging biomarker-based infectious disease diagnostics player targeting clinical decision support.
Broad incumbents
- bioMérieux (BioFire Diagnostics): Global IVD leader whose BioFire FilmArray syndromic panels are widely used for rapid infection identification, including musculoskeletal infections. Comparable as a broad incumbent in clinical microbiology diagnostics with overlapping hospital accounts.
- Cepheid (Danaher): Operates the GeneXpert molecular diagnostics platform used across hospitals for infectious disease testing, including orthopedic and prosthetic joint infection workups. Comparable as a broad incumbent with hospital-based IVD offerings.
- Becton, Dickinson and Company (BD): Large diversified medical technology company with a diagnostics segment spanning microbiology, molecular, and immunoassays, including products relevant to orthopedic infection diagnostics. Serves similar hospital and reference-lab customers.
- Hologic: Developer of molecular diagnostic systems (e.g., Panther) used in infectious disease testing across hospitals and reference labs. Comparable as a broad-incumbent IVD player serving similar clinical customers.
- QuidelOrtho: Specializes in clinical immunoassays and rapid diagnostic kits across hospital and reference lab channels. Directly comparable in the IVD immunoassay kit business model and orthopedic/healthcare lab end-markets.
- Bio-Rad Laboratories: Manufactures clinical diagnostic products including immunoassay kits, quality controls, and lab instruments used in hospital and reference laboratories. Comparable as an IVD kit manufacturer serving the same lab and orthopedic diagnostic workflows.
- Stryker: Large orthopedic medical device competitor to Zimmer Biomet with overlapping sales channels into orthopedic surgery centers and hospitals. Comparable as a broad-incumbent that operates in the same customer ecosystem and could potentially field competing PJI diagnostics or bundled offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CD Diagnostics social profiles
Digital presenceCD Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
CD Diagnostics leadership team
Management profileNumber of profiles
Profiles4 records
CD Diagnostics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CD Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CD Diagnostics
What does CD Diagnostics do?
CD Diagnostics develops and sells proprietary immunoassay-based diagnostic test kits under the Synovasure brand for detecting periprosthetic joint infection (PJI) in synovial fluid via alpha defensin biomarkers. The portfolio includes a point-of-care lateral flow test kit, a laboratory-based ELISA test, microbial identification tests, a quality control kit, and the SynTuition laboratory developed test. These products are sold to orthopedic surgeons, hospitals, and clinical laboratories globally.
Is CD Diagnostics a public or private company?
CD Diagnostics is a private company. It is classified as corporate owned and is currently acquired.
When was CD Diagnostics founded?
CD Diagnostics was founded in 2008. It employs 11 to 50 people.
Where is CD Diagnostics based?
CD Diagnostics is headquartered in Claymont, United States, in the North America region.
How does CD Diagnostics make money?
One revenue line is on record: diagnostic Test Kits and Consumables.
Who are CD Diagnostics's main competitors?
Accelerate Diagnostics is listed as a direct peer. Emerging players are T2 Biosystems and Inflammatix. Broad incumbents are bioMérieux (BioFire Diagnostics), Cepheid (Danaher), Becton, Dickinson and Company (BD), Hologic, QuidelOrtho, Bio-Rad Laboratories and Stryker.
Does CD Diagnostics have an API?
No public API is recorded for CD Diagnostics.
What industry is CD Diagnostics in?
CD Diagnostics's product category is Orthopedic In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAJ, Companion Diagnostics (CDx) & Precision Medicine IVD, with a secondary code of HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 325413 and its SIC code is 2835.